Engage Technologies Group Raises $15M in Series A Funding

engage

Engage Technologies Group, Inc., a Boise, Idaho-based creator of a Human Experience Platform for the healthcare Industry, raised $15m in Series A financing.

Series A investors consist of individual healthcare professionals who are customers.

The company plans to use the proceeds to enter new markets and create rich video content that aligns the patient journey from diagnosis to recovery.

Led by Michael Boerner, CEO and Founder, and by C. Lloyd Mahaffey, EVP & Chief Operating Officer, Engage Technologies provides a SaaS Human Experience Platform for the healthcare Industry which aims to enable a simplified workflow, primarily focused on improving and accelerating the pathway-to-purchase and end-to-end customer/patient experience.

Accessed directly from the end customer’s cell phone, Engage delivers 90-second episodic, drip or event-based content that is white-labeled for clinic or manufacturer branding.

The company is working with subject matter experts on next-generation mobile video engagement technologies in multiple healthcare market verticals including, but not limited to, Dental, Ocular, Aesthetics and Health/Orthopedic. In addition to some of the top medical practitioners in their respective fields, current product manufacturer clients include leading brands across Aesthetics, Ocular, Dental and Health sectors.

In conjunction with the deal, Engage has introduced a number of medical professionals to the board of directors including:

  • W. Grant Stevens, MD, FACS, Chairman of Cle’ Global Aesthetics and Clinical Professor of Surgery at USC-Keck School of Medicine, Division of Plastic Surgery;
  • Dr. Jerry Sude, Co-founder, President of Novus Clinic and Co-founder of OD Excellence; 
  • Robert J. Cionni, MD, former surgeon at The Eye Institute of Utah and former President of the American Society of Cataract and Refractive Surgery; 
  • Lon McRae, DDS, Founder and President of McRae Dental and Founding Member of Smiles for Life Foundation.

FinSMEs

27/04/2021